Search results
Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoCoherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript March 13, 2024 Coherus...
Coherus BioSciences Inc (CHRS) Reports Growth in Net Revenue for Q4 and Full Year 2023 Despite ...
GuruFocus.com via Yahoo Finance· 3 months agoNet Revenue: Coherus BioSciences Inc (NASDAQ:CHRS) reported a significant increase in net revenue to...
Coherus BioSciences Inc (CHRS) Reports 27% Rise in Q3 2023 Net Revenue
GuruFocus.com via Yahoo Finance· 7 months agoCoherus BioSciences Inc (NASDAQ:CHRS) reports a 27% increase in net revenue from the prior quarter,...
In the wake of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) latest US$49m market cap drop,...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Institutions' substantial holdings in Coherus BioSciences implies that they have...
With 72% institutional ownership, Coherus BioSciences, Inc. (NASDAQ:CHRS) is a favorite amongst the...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights Institutions' substantial holdings in Coherus BioSciences implies that they have...
Coherus BioSciences, Inc. (NASDAQ:CHRS) Held Back By Insufficient Growth Even After Shares Climb 30%
Simply Wall St. via Yahoo Finance· 1 year agoThose holding Coherus BioSciences, Inc. (NASDAQ:CHRS) shares would be relieved that the share price...
We Think Some Shareholders May Hesitate To Increase Coherus BioSciences, Inc.'s (NASDAQ:CHRS) CEO...
Simply Wall St. via Yahoo Finance· 2 weeks agoKey Insights Coherus BioSciences to hold its Annual General Meeting on 29th of May Salary of...
When Can We Expect A Profit From Coherus BioSciences, Inc. (NASDAQ:CHRS)?
Simply Wall St. via Yahoo Finance· 1 month agoWith the business potentially at an important milestone, we thought we'd take a closer look at...
News Flash: 8 Analysts Think Coherus BioSciences, Inc. (NASDAQ:CHRS) Earnings Are Under Threat
Simply Wall St. via Yahoo Finance· 1 year agoOne thing we could say about the analysts on Coherus BioSciences, Inc. (NASDAQ:CHRS) - they aren't...
Analysts Are More Bearish On Coherus BioSciences, Inc. (NASDAQ:CHRS) Than They Used To Be
Simply Wall St. via Yahoo Finance· 4 months agoThe latest analyst coverage could presage a bad day for Coherus BioSciences, Inc. (NASDAQ:CHRS),...